Kane Biotech Inc. announced that it has filed a patent on its revyveTM Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510 (k) cleared revyveTM Antimicrobial Wound Gel, and will be introducing it at the Boswick Burn and Wound Care Symposium.